Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20.56	17.67	17.01	26.21	41.64
Cash & Short-Term Investments	20.56	17.67	17.01	26.21	41.64
Cash Growth	16.35%	3.86%	-35.09%	-37.05%	363.07%
Accounts Receivable	1.6	1	2.93	1.66	2.3
Other Receivables	0.71	1.63	2.29	6.82	0.47
Receivables	2.31	2.63	5.22	8.47	2.77
Prepaid Expenses	1.12	0.75	1.57	1.31	0.42
Total Current Assets	23.98	21.04	23.8	36	44.82
Property, Plant & Equipment	0.16	0.22	0.31	0.28	0.18
Long-Term Investments	-	0	0	0	0
Long-Term Deferred Charges	74.43	73.5	75.99	65.5	56.66
Total Assets	98.58	94.76	100.11	101.78	101.66
Accounts Payable	0.93	3.09	1.97	4.34	1.96
Accrued Expenses	3.18	2.85	3.53	2.45	4.56
Other Current Liabilities	0.71	1.91	1.29	0.4	2.91
Total Current Liabilities	4.82	7.85	6.79	7.19	9.43
Total Liabilities	4.82	7.85	6.79	7.19	9.43
Common Stock	3.2	3.06	2.69	2.69	2.69
Additional Paid-In Capital	192.81	171.39	155.19	155.19	155.19
Retained Earnings	-102.25	37.39	61.27	54.92	36.83
Comprehensive Income & Other	-	-124.92	-125.83	-118.21	-102.47
Shareholders' Equity	93.76	86.91	93.32	94.59	92.23
Total Liabilities & Equity	98.58	94.76	100.11	101.78	101.66
Net Cash (Debt)	20.56	17.67	17.01	26.21	41.64
Net Cash Growth	16.35%	3.86%	-35.09%	-37.05%	363.07%
Net Cash Per Share	0.83	0.81	0.79	1.19	2.04
Filing Date Shares Outstanding	25.61	24.49	21.49	21.49	21.49
Total Common Shares Outstanding	25.61	24.49	21.49	21.49	21.49
Working Capital	19.16	13.2	17.01	28.8	35.39
Book Value Per Share	3.66	3.55	4.34	4.40	4.29
Tangible Book Value	93.76	86.91	93.32	94.59	92.23
Tangible Book Value Per Share	3.66	3.55	4.34	4.40	4.29
Machinery	-	1.27	1.27	1.14	0.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.